Results 171 to 180 of about 4,071 (233)

Scleral Thickness following Fluocinolone Acetonide Implant (Retisert)

Ocular Immunology and Inflammation, 2010
To evaluate whether intravitreal fluocinolone acetonide (FA) implantation (Retisert) leads to scleral thinning.Scleral thickness was measured at the pars plana region (4 quadrants) with anterior segment OCT (Visante) in FA implanted eyes (18) with noninfectious posterior uveitis in comparison to eyes with prior vitrectomy (8), and normal eyes without ...
Mehran, Taban, Careen Y, Lowder, Alexandre A C M, Ventura, Sumit, Sharma, Benjamin, Nutter, Brandy C, Hayden, William J, Dupps, Peter K, Kaiser   +7 more
openaire   +2 more sources

Cytomegalovirus Retinitis After Fluocinolone Acetonide (Retisert™) Implant

American Journal of Ophthalmology, 2007
To report a case of cytomegalovirus (CMV) retinitis after placement of a fluocinolone acetonide (Retisert) implant.Interventional case report.Retrospective chart review.A 65-year-old man with a history of Adamantiades-Behcet disease and bilateral recurrent uveitis that was unresponsive to systemic corticosteroid-sparing immunosuppressive therapy ...
Rafael L, Ufret-Vincenty, Rishi P, Singh, Careen Y, Lowder, Peter K, Kaiser   +3 more
openaire   +2 more sources

ANTERIOR MIGRATION OF INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANTS: A CASE REPORT

RETINAL Cases & Brief Reports, 2022
Background/Purpose: To describe management of anterior migration of a fluocinolone acetonide(FAc) intravitreal implant. Methods: A retrospective case report. A 61-year-old man with diabetic macular edema and prior vitrectomy had anterior migration of a FAc implant.
Robert C, Gunzenhauser, Margaret A, Greven, Vishak J, John   +2 more
openaire   +2 more sources

Fluocinolone acetonide implant in diabetic macular edema: International experts’ panel consensus guidelines and treatment algorithm

European Journal of Ophthalmology, 2022
Center-involving diabetic macular edema (DME) is a leading cause of vision impairment in working-age adults. While its management is particularly challenging in a poorly compliant population, continuous innovation and the advent of new molecules have ...
L. Kodjikian, F. Bandello, M. D. de Smet, C. Dot, J. Zarranz-Ventura, A. Loewenstein, A. Sudhalkar, A. Bilgic, J. Cunha-Vaz, W. Dirven, F. Behar-Cohen, T. Mathis   +11 more
semanticscholar   +1 more source

Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema – two years results

European Journal of Ophthalmology, 2022
Purpose We report visual and anatomical outcomes of chronic postoperative macular edema treated with a fluocinolone acetonide intravitreal implant.
A. Chronopoulos, P. Chronopoulos, L. Hattenbach, A. Ashurov, J. Schutz, N. Pfeiffer, C. Korb   +6 more
semanticscholar   +1 more source

Elevated Intraocular Pressure Associated With Anterior Chamber Migration of Fluocinolone Acetonide Implant 1 Year After Administration.

JAMA ophthalmology, 2022
This case report describes the migration of a fluocinolone acetonide implant to the anterior chamber 1 year after it was placed.
Emilie Jomaa, C. Schweitzer, M. Delyfer
semanticscholar   +1 more source

Fluocinolone acetonide implant (Iluvien®) for macular edema associated with retinitis pigmentosa: A case report

European Journal of Ophthalmology, 2022
Purpose Macular edema can be observed in 20% of patients with retinitis pigmentosa (RP) and is often responsible of central vision impairment. Intraocular administration of corticosteroids (either triamcinolone or dexamethasone implant) has been found to
E. Jomaa, M. Delyfer, J. Korobelnik
semanticscholar   +1 more source

Fluocinolone Acetonide Intravitreal Implants in Vogt-Koyanagi-Harada Disease

Ocular Immunology and Inflammation, 2009
To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH).Interventional case series.Retrospective review of medical records.Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone ...
Yousuf, Khalifa, Allison R, Loh, Nisha R, Acharya   +2 more
openaire   +2 more sources

Fluocinolone Acetonide Intravitreal Implant (Iluvien®)

Drugs, 2013
Fluocinolone acetonide intravitreal implant (Iluvien®) is an injectable, non-erodible, corticosteroid implant that is approved in several European countries for the treatment of chronic diabetic macular oedema (DMO). In analyses of two multinational trials in patients with DMO previously treated with macular laser photocoagulation, fluocinolone ...
openaire   +2 more sources

Long-Term Treatment Outcomes with a Single 0.19 Mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis – A Real-World Study

Ocular immunology and inflammation
Purpose To evaluate time to first additional treatment following intravitreal 0.19 mg fluocinolone acetonide (FAc) in non-infectious uveitis with posterior segment involvement (NIU-PS) in a real-world setting.
Warda Darwisch, M. Waizel, Robert P Finger, Kai Januschowski, B. Seitz, Fabian N Fries, Annekatrin Rickmann   +6 more
semanticscholar   +1 more source